A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanoma

Damian A. Laber; Roseline I. Okeke; Carlos Arce-Lara; Beverly S. Taft; Cassandra L. Schonard; Kelly M. McMasters; Goetz H. Kloecker; Donald M. Miller

首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanoma

【24h】

A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanoma

机译：扩大剂量替莫唑胺和沙利度胺在先前治疗的转移性黑色素瘤患者中的II期研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

To assess the efficacy and tolerability of extended dose temozolomide and continuous thalidomide in patients with advanced metastatic cutaneous melanoma.

机译：评估扩大剂量的替莫唑胺和连续停用沙利度胺在晚期转移性皮肤黑色素瘤患者中的疗效和耐受性。

著录项

来源
《Journal of Cancer Research and Clinical Oncology》 |2006年第9期|611-616|共6页
作者
Damian A. Laber; Roseline I. Okeke; Carlos Arce-Lara; Beverly S. Taft; Cassandra L. Schonard; Kelly M. McMasters; Goetz H. Kloecker; Donald M. Miller;
展开▼
作者单位

J. G. Brown Cancer Center University of Louisville;

J. G. Brown Cancer Center University of Louisville;

J. G. Brown Cancer Center University of Louisville;

J. G. Brown Cancer Center University of Louisville;

J. G. Brown Cancer Center University of Louisville;

J. G. Brown Cancer Center University of Louisville;

J. G. Brown Cancer Center University of Louisville;

J. G. Brown Cancer Center University of Louisville;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Melanoma; Temozolomide; Thalidomide;

机译：黑色素瘤;替莫唑胺;沙利度胺;

相似文献

外文文献
中文文献
专利

1. A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanoma. [J] . Laber DA, Okeke RI, Arce Lara C, Journal of Cancer Research and Clinical Oncology . 2006,第9期

机译：在先前治疗过的转移性黑色素瘤患者中，延长剂量的替莫唑胺和沙利度胺的II期研究。
2. Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group study. [J] . Atkins MB, Sosman JA, Agarwala S, Cancer: A Journal of the American Cancer Society . 2008,第8期

机译：替莫唑胺，沙利度胺和全脑放射疗法治疗转移性黑色素瘤脑转移患者：细胞因子工作组II期研究。
3. Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma. [J] . Hwu WJ, Krown SE, Menell JH, Journal of Clinical Oncology . 2003,第17期

机译：替莫唑胺与沙利度胺治疗转移性黑色素瘤的II期研究。
4. Preliminary results of a phase I/II clinical trial using in situ photoimmunotherapy combined with imiquimod for metastatic melanoma patients [C] . Xiaosong Li, Mark F. Naylor, Robert E. Nordquist, . 2010

机译：使用原位光免疫疗法联合咪喹莫特治疗转移性黑色素瘤患者的I / II期临床试验的初步结果
5. A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin [D] . Venkatramani, Rajkumar. 2010

机译：长春新碱，伊非替康，替莫唑胺和贝伐单抗（VIT-B）逐步剂量在患有非造血源性复发或难治性实体瘤的儿童和青少年患者中的I期研究
6. Phase II Trial of Combination Thalidomide plus Temozolomide in Patients with Metastatic Malignant Melanoma: Southwest Oncology Group S0508 [O] . Joseph I. Clark, James Moon, Laura F. Hutchins, -1

机译：二期试验组合沙利度胺加替代毒物转移性恶性黑素瘤患者：西南肿瘤组S0508
7. Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain [O] . Susan E. Krown, Donna Niedzwiecki, Wen-Jen Hwu, 2006

机译：粒瘤和沙利度胺对大脑转移黑素瘤患者的II期研究

A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanoma

摘要

著录项

相似文献

相关主题

期刊订阅